Literature DB >> 29590656

Epiretinal Proliferations Associated with Lamellar Macular Holes: Clinical and Surgical Implications.

Marco Frederico Marques1,2, Sónia Rodrigues3, Miguel Raimundo1, José Costa1, João Pedro Marques1,2,4, Mário Alfaiate1, João Figueira1,2,3,4,5.   

Abstract

OBJECTIVES: To describe the prevalence of lamellar hole-associated epiretinal proliferation (LHEP) and to correlate this finding with lamellar macular hole (LMH) morphology and prognosis after a surgical or conservative approach.
METHODS: This is a retrospective multicenter case series comprising consecutive LMH patients followed for ≥6 months. Serial spectral-domain optical coherence tomographies were evaluated for the presence of epiretinal membrane (ERM) and LHEP, diameter of the LMH aperture, base, and floor thickness. Pars plana vitrectomy with ERM and internal limiting membrane peeling was performed in the surgical cases.
RESULTS: A total of 62 eyes from 57 consecutive patients were included. Mean follow-up time was 27.1 ± 19.8 months. LHEP was observed in 33 (53.2%) eyes. Patients with LMH and LHEP presented a larger external diameter (p = 0.001) and thinner floors (p = 0.018). Twenty-seven (81.8%) of the patients with LMH and LHEP presented a degenerative intraretinal cavitation, compared to 23.3% in the non-LHEP group (p = 0.001). No differences were observed in visual performance or closure rate between the 2 groups after surgery or in the subset of patients followed conservatively.
CONCLUSIONS: LHEP was correlated with the anatomical conformation of the LMH, yielding thinner floors and larger external diameters. However, it did not correlate with the anatomical or functional results, both in the patients who underwent surgery and in those managed conservatively.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Diseases of the retina and vitreous; Image analysis; Macular hole; Optical coherence tomography

Mesh:

Year:  2018        PMID: 29590656     DOI: 10.1159/000486691

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  7 in total

1.  Characterization of Epiretinal Proliferation in Full-Thickness Macular Holes and Effects on Surgical Outcomes.

Authors:  Esther Lee Kim; Adam J Weiner; Cindy Ung; Miin Roh; Jay Wang; Ivan J Lee; Natalie T Huang; Maxwell Stem; Mohammad Dahrouj; Dean Eliott; Demetrios G Vavvas; Lucy H Y Young; George A Williams; Bruce R Garretson; Ivana K Kim; Tarek S Hassan; Shizuo Mukai; Alan J Ruby; Lisa J Faia; Antonio Capone; Jason Comander; Leo A Kim; David M Wu; Kimberly A Drenser; Maria A Woodward; Jeremy D Wolfe; Yoshihiro Yonekawa
Journal:  Ophthalmol Retina       Date:  2019-04-01

Review 2.  The clinical and pathogenic significance of atypical epiretinal tissue in macular hole.

Authors:  Sungsoon Hwang; Se Woong Kang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-07-15       Impact factor: 3.535

Review 3.  [Biomarkers in full-thickness and lamellar defects of the macula].

Authors:  M Maier; R Schumann; J Friedrich; J Klaas; C Haritoglou
Journal:  Ophthalmologe       Date:  2021-03-01       Impact factor: 1.174

4.  Structural and Functional Outcomes of Surgery for Lamellar Macular Holes with or without Epimacular Proliferations.

Authors:  Ramesh Venkatesh; Arpitha Pereira; Kushagra Jain; Naresh Kumar Yadav
Journal:  J Ophthalmic Vis Res       Date:  2022-01-21

Review 5.  Primary Lamellar Macular Holes: To Vit or Not to Vit.

Authors:  Lihteh Wu; Ryan Bradshaw
Journal:  J Clin Med       Date:  2022-08-28       Impact factor: 4.964

Review 6.  The Management of Lamellar Macular Holes: A Review.

Authors:  Ciprian Danielescu; Horia Tudor Stanca; Florian Balta
Journal:  J Ophthalmol       Date:  2020-02-21       Impact factor: 1.909

7.  Surgery outcomes of lamellar macular eyes with or without lamellar hole-associated epiretinal proliferation: a meta-analysis.

Authors:  Hanyue Xu; Ling Qin; Yifan Zhang; Yinan Xiao; Ming Zhang
Journal:  BMC Ophthalmol       Date:  2020-08-25       Impact factor: 2.209

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.